Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Journal of Veterinary Pharmacology and Therapeutics
|
April 1, 2016
Topical delivery of diclofenac into and across equine skin from a novel liquid diclofenac epolamine formulation
S Del Río-Sancho, D Concas, P Oreste, et al.
The Biochemical Journal
|
September 1, 1981
The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies
B Casu, P Oreste, G Torri, et al.
Thrombosis Research
|
May 1, 1980
Anti-Xa active heparin oligosaccharides
J Choay, J C Lormeau, M Petitou, et al.
Lancet (London, England)
|
May 9, 1987
Bleeding associated with heparin contaminants
B Casu, A Naggi, P Oreste, et al.
The Journal of Biological Chemistry
|
July 27, 2001
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives
D Leali, M Belleri, C Urbinati, et al.
Haematologica
|
July 20, 2004
Traumatic left shoulder fracture masking aggressive granuloblastic sarcoma in a CML patient
P Cozzi, A Nosari, S Cantoni, et al.
Arzneimittel-Forschung
|
January 1, 1983
Correlation between structure, fat-clearing and anticoagulant properties of heparins and heparan sulphates
B Casu, E A Johnson, M Mantovani, et al.
Arzneimittel-Forschung
|
April 1, 1986
Retention of antilipemic activity by periodate-oxidized non-anticoagulant heparins
B Casu, G Diamantini, G Fedeli, et al.
British Journal of Haematology
|
December 1, 1996
Anaplastic large cell (CD30/Ki-1+) lymphoma in HIV+ patients: clinical and pathological findings in a group of ten patients
A Nosari, S Cantoni, P Oreste, et al.
The Journal of Biological Chemistry
|
April 25, 1997
Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size
M Rusnati, D Coltrini, P Oreste, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Journal of Veterinary Pharmacology and Therapeutics
|
April 1, 2016
Topical delivery of diclofenac into and across equine skin from a novel liquid diclofenac epolamine formulation
S Del Río-Sancho, D Concas, P Oreste, et al.
The Biochemical Journal
|
September 1, 1981
The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence. Chemical and 13C nuclear-magnetic-resonance studies
B Casu, P Oreste, G Torri, et al.
Thrombosis Research
|
May 1, 1980
Anti-Xa active heparin oligosaccharides
J Choay, J C Lormeau, M Petitou, et al.
Lancet (London, England)
|
May 9, 1987
Bleeding associated with heparin contaminants
B Casu, A Naggi, P Oreste, et al.
The Journal of Biological Chemistry
|
July 27, 2001
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives
D Leali, M Belleri, C Urbinati, et al.
Haematologica
|
July 20, 2004
Traumatic left shoulder fracture masking aggressive granuloblastic sarcoma in a CML patient
P Cozzi, A Nosari, S Cantoni, et al.
Arzneimittel-Forschung
|
January 1, 1983
Correlation between structure, fat-clearing and anticoagulant properties of heparins and heparan sulphates
B Casu, E A Johnson, M Mantovani, et al.
Arzneimittel-Forschung
|
April 1, 1986
Retention of antilipemic activity by periodate-oxidized non-anticoagulant heparins
B Casu, G Diamantini, G Fedeli, et al.
British Journal of Haematology
|
December 1, 1996
Anaplastic large cell (CD30/Ki-1+) lymphoma in HIV+ patients: clinical and pathological findings in a group of ten patients
A Nosari, S Cantoni, P Oreste, et al.
The Journal of Biological Chemistry
|
April 25, 1997
Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size
M Rusnati, D Coltrini, P Oreste, et al.
Page
of 4